J. Michael Pearson

2010 - Valeant Pharmaceuticals International

In 2010, J. Michael Pearson earned a total compensation of $4.8M as Chief Executive Officer at Valeant Pharmaceuticals International.

Compensation breakdown

Non-Equity Incentive Plan$750,000
Salary$387,500
Stock Awards$3,606,966
Other$10,867
Total$4,755,333

Pearson received $3.6M in stock awards, accounting for 76% of the total pay in 2010.

Pearson also received $750K in non-equity incentive plan, $387.5K in salary and $10.9K in other compensation.

Rankings

In 2010, J. Michael Pearson's compensation ranked 1,114th out of 10,438 executives tracked by ExecPay. In other words, Pearson earned more than 89.3% of executives.

ClassificationRankingPercentile
All
1,114
out of 10,438
89th
Division
Manufacturing
416
out of 3,843
89th
Major group
Chemicals And Allied Products
88
out of 917
90th
Industry group
Drugs
50
out of 676
93rd
Industry
Pharmaceutical Preparations
42
out of 474
91st
Source: SEC filing on April 30, 2012.

Pearson's colleagues

We found eight more compensation records of executives who worked with J. Michael Pearson at Valeant Pharmaceuticals International in 2010.

2010

William Wells

Valeant Pharmaceuticals International

Chief Executive Officer

2010

Gilbert Godin

Valeant Pharmaceuticals International

Chief Operating Officer

2010

Margaret Mulligan

Valeant Pharmaceuticals International

Chief Financial Officer

2010

Gregory Gubitz

Valeant Pharmaceuticals International

General Counsel

2010

Rajiv De Silva

Valeant Pharmaceuticals International

Chief Operating Officer

2010

Robert Chai-Onn

Valeant Pharmaceuticals International

General Counsel

2010

Mark Durham

Valeant Pharmaceuticals International

Senior Vice President, Human Resources

2010

Philip Loberg

Valeant Pharmaceuticals International

Chief Financial Officer

You may also like